Literature DB >> 12807827

Effector T cells have a lower ligand affinity threshold for activation than naive T cells.

Kazuhiko Kimachi1, Katsuji Sugie, Howard M Grey.   

Abstract

It has been previously established that effector and memory T cells are more sensitive to antigen stimulation than naive T cells. In this study, we compared the effect of ligand affinity on the activation of naive and effector T cells derived from pigeon cytochrome c (PCC)-specific TCR transgenic mice by stimulating these cells with a variety of ligands with widely differing antigenicity. The data obtained indicated the following. (i) The differences in antigen dose requirements for activation of naive and effector cells widened as the affinity of the antigen decreased. Most dramatically, peptides that were TCR antagonists for naive T cells were recognized as agonists by effector T cells. (ii) While both naive and effector T cells were activated by the bacterial superantigen staphylococcal enterotoxin A, specific for the transgenic TCR V(beta)3 chain, effector, but not naive, T cells were stimulated to proliferate by toxic shock syndrome toxin-1, a superantigen not previously described to be stimulatory for V(beta)3 T cells. (iii) Effector T cells, but not naive cells, proliferated in response to endogenous self-peptides presented by antigen-presenting cells in a syngeneic mixed lymphocyte reaction. Taken together these data indicate that effector T cells have a lower affinity threshold for activation than naive T cells. Further studies demonstrated that the heightened reactivity of effector T cells to low-affinity ligands declined progressively with repeated stimulations by antigen such that after repeated stimulation effector T cells were no longer stimulated by low-affinity ligands but recognized them as TCR antagonists similar to naive T cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12807827     DOI: 10.1093/intimm/dxg087

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  13 in total

Review 1.  Cross-reactivity of T cells and its role in the immune system.

Authors:  Galina Petrova; Andrea Ferrante; Jack Gorski
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

2.  Induction of regulatory T-cells from memory T-cells is perturbed during acute exacerbation of multiple sclerosis.

Authors:  Imran H Mohiuddin; Vinodh Pillai; Ethan J Baughman; Benjamin M Greenberg; Elliot M Frohman; Michael P Crawford; Sushmita Sinha; Nitin J Karandikar
Journal:  Clin Immunol       Date:  2016-05-03       Impact factor: 3.969

3.  Augmenting antitumor T-cell responses to mimotope vaccination by boosting with native tumor antigens.

Authors:  Jonathan D Buhrman; Kimberly R Jordan; Lance U'ren; Jonathan Sprague; Charles B Kemmler; Jill E Slansky
Journal:  Cancer Res       Date:  2012-11-16       Impact factor: 12.701

4.  Enhanced Tim3 activity improves survival after influenza infection.

Authors:  Josalyn L Cho; Marly I Roche; Barry Sandall; Abraham L Brass; Brian Seed; Ramnik J Xavier; Benjamin D Medoff
Journal:  J Immunol       Date:  2012-08-08       Impact factor: 5.422

5.  CD8 T cell recall responses are regulated by the tissue tropism of the memory cell and pathogen.

Authors:  Kimberly D Klonowski; Amanda L Marzo; Kristina J Williams; Seung-Joo Lee; Quynh-Mai Pham; Leo Lefrançois
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

6.  Antigen signal strength during priming determines effector CD4 T cell function and antigen sensitivity during influenza virus challenge.

Authors:  Mika Nagaoka; Yasuko Hatta; Yoshihiro Kawaoka; Laurent P Malherbe
Journal:  J Immunol       Date:  2014-08-01       Impact factor: 5.422

7.  Characterization of a surrogate murine antibody to model anti-human CD3 therapies.

Authors:  Fabien Dépis; Eric Hatterer; Romain Ballet; Bruno Daubeuf; Laura Cons; Sophie Glatt; Walter Reith; Marie Kosco-Vilbois; Yann Dean
Journal:  MAbs       Date:  2013-04-18       Impact factor: 5.857

8.  Cumulative autoimmunity: T cell clones recognizing several self-epitopes exhibit enhanced pathogenicity.

Authors:  Roland S Liblau; Hartmut Wekerle; Roland M Tisch
Journal:  Front Immunol       Date:  2011-10-05       Impact factor: 7.561

9.  Immunisation with 'naïve' syngeneic dendritic cells protects mice from tumour challenge.

Authors:  M J Grimshaw; K Papazisis; G Picco; H Bohnenkamp; T Noll; J Taylor-Papadimitriou; J Burchell
Journal:  Br J Cancer       Date:  2008-02-05       Impact factor: 7.640

10.  Diversity and recognition efficiency of T cell responses to cancer.

Authors:  Tor B Stuge; Susan P Holmes; Sahdev Saharan; Andrea Tuettenberg; Mario Roederer; Jeffrey S Weber; Peter P Lee
Journal:  PLoS Med       Date:  2004-11-30       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.